R1 RCM Reports Fourth Quarter and Full Year 2019 Results

CHICAGO, Feb. 20, 2020 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months and year ended December 31, 2019.
Fourth Quarter 2019 Results:Revenue of $314.0 million, up $51.1 million and 19.4% compared to the same period last yearGAAP net income of $7.8 million, compared to GAAP net loss of $5.7 million in the same period last yearAdjusted EBITDA of $45.1 million, up $18.0 million compared to the same period last yearFull Year 2019 Results:Revenue of $1,186.1 million, up $317.6 million and 36.6% compared to 2018GAAP net income of $12.0 million, compared to GAAP net loss of $45.3 million in 2018Adjusted EBITDA of $168.0 million, up $111.0 million compared to 2018“2019 was an excellent year for R1. We added $4.1 billion in new net patient revenue under management from a diverse customer base, and our continued focus on operational execution drove meaningful bottom-line growth. At the same time, we made significant investments in technology and mobilized our physician offering to capture the market opportunity ahead of us,” said Joe Flanagan, President and Chief Executive Officer of R1. “We enter 2020 with good momentum across the business. Market demand for our offerings continues to grow, and the investments we are making in expanding our functionality and capabilities continue to improve our competitive position and extend our lead in the market.”“We generated significant earnings growth in 2019, driven by solid execution across our contracted book of business,” added Rick Evans, Interim Chief Financial Officer and Chief Accounting Officer. “We remain focused on operational execution to deliver on our financial goals for 2020, while making investments to drive growth beyond 2020.”2020 OutlookFor 2020, R1 expects to generate:Revenue of between $1,300 million and $1,400 millionGAAP operating income of $145 million to $165 millionAdjusted EBITDA of $260 million to $275 millionConference Call and Webcast DetailsR1’s management team will host a conference call today at 8:00 a.m. Eastern Time to discuss its financial results and business outlook. To participate, please dial 866-393-4306 (734-385-2616 outside the U.S. and Canada) using conference code number 4276889. A live webcast and replay of the call will be available at the Investor Relations section of the Company’s web site at ir.r1rcm.com.Non-GAAP Financial MeasuresIn order to provide a more comprehensive understanding of the information used by R1’s management team in financial and operational decision making, the Company supplements its GAAP consolidated financial statements with certain non-GAAP financial performance measures, including adjusted EBITDA and net debt. Adjusted EBITDA is defined as GAAP net income before net interest income/expense, income tax provision/benefit, depreciation and amortization expense, share-based compensation expense, expense arising from debt extinguishment, strategic initiatives costs, transitioned employee restructuring expense, digital transformation office expenses, and certain other items. Net debt is defined as debt less cash and cash equivalents, inclusive of restricted cash.Our board and management team use adjusted EBITDA as (i) one of the primary methods for planning and forecasting overall expectations and for evaluating actual results against such expectations and (ii) a performance evaluation metric in determining achievement of certain executive incentive compensation programs, as well as for incentive compensation programs for employees.Tables 4 through 9 present a reconciliation of GAAP financial measures to non-GAAP financial measures, including adjusted EBITDA. Adjusted EBITDA should be considered in addition to, but not as a substitute for, the information prepared in accordance with GAAP.Forward Looking StatementsThis press release includes information that may constitute “forward-looking statements,” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future, not past, events and often address our expected future growth, plans and performance or forecasts. These forward-looking statements are often identified by the use of words such as “anticipate,” “believe,” “designed,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “will,” or “would,” and similar expressions or variations, although not all forward-looking statements contain these identifying words. Such forward-looking statements are based on management’s current expectations about future events as of the date hereof and involve many risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in our forward-looking statements. Subsequent events and developments, including actual results or changes in our assumptions, may cause our views to change. We do not undertake to update our forward-looking statements except to the extent required by applicable law. Readers are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements included herein are expressly qualified in their entirety by these cautionary statements. Our actual results and outcomes could differ materially from those included in these forward-looking statements as a result of various factors, including, but not limited to, the expected timing of onboarding new business deployment, our ability to integrate acquired businesses as planned and to realize the expected benefits from acquisitions, our ability to successfully deliver on our commitments to our customers, fluctuations in our results of operations and cash flows, and the factors discussed under the heading “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2018, our quarterly reports on Form 10-Q and any other periodic reports that the Company files with the Securities and Exchange Commission.About R1 RCMR1 RCM is a leading provider of technology-enabled RCM services which transform and solve revenue cycle performance challenges across hospitals, health systems and group physician practices. R1’s proven and scalable operating models seamlessly complement a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. To learn more, visit: r1rcm.com.Contact:R1 RCM Inc.Investor Relations:Atif Rahim
312-324-5476
[email protected]
Media Relations:Media Relations:
Natalie Joslin
678.585.1206
[email protected]



(1) Loss on debt extinguishment represents the loss associated with the repayment of the credit agreement and subordinated notes in June 2019.
(2) Other costs are comprised of strategic initiatives costs, transitioned employee restructuring expense, Digital Transformation Office expenses, and certain other costs.





Bay Street News

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search